The following words or terms, when used in this Chapter, shall have the following meaning, unless the context clearly indicates otherwise: "Advisory Council" means the advisory council on lead poisoning prevention.
"Anticipatory guidance" means providing parents or guardians of children under the age of six with information regarding the major causes of lead poisoning and means of preventing lead exposure. Such guidance shall be pertinent to the environment of the child.
"Blood lead screening" refers to measuring lead concentration by capillary or venous collection to identify elevated blood lead levels.
"CLIA '88'" means the Clinical Laboratory Improvement Amendments of 1988, public law 100-578. This amendment applies to the Federal Law that governs laboratories who examine human specimens for the diagnosis, prevention, or treatment of any disease or impairment, or the assessment of the health of human beings.
"Confirmatory testing" refers to a blood lead concentration measured on venous blood.
"Department" refers to the Oklahoma State Department of Health.
"Dwelling" refers to a building or structure thereof, including the property occupied by and appurtenant to such dwelling, which is occupied in whole or in part as the home, residence or sleeping place of one or more human beings and shall without limiting the foregoing, include child care facilities for children under six years of age, schools and nursery schools.
"Elevated blood lead level" means a confirmed concentration of lead of 10 micrograms (μg) per deciliter (dL) or greater.
"Environmental management" refers to on-site dwelling environmental investigation and exposure assessment, sampling for lead, environmental testing and reporting, notice of conditions conducive to lead poisoning, environmental intervention.
"Follow-up" refers to actions by local health departments and health care providers which, depending on the blood lead level and exposure history of the child shall include as appropriate: risk reduction education, follow-up testing, confirmatory testing, medical evaluation, medical management, environmental management and case management, in accordance with generally accepted medical standards and public health guidelines.
"Health care provider" means any health professional or facility authorized to conduct blood lead screening.
"High risk lead exposure" refers to any positive response on the risk assessment questionnaire.
"Laboratory" refers to the Oklahoma State Department of Health Laboratory or a laboratory approved by the Oklahoma State Department of Health to conduct blood lead measurement.
"Low risk lead exposure" refers to negative responses to all questions on the risk assessment questionnaire.
"Person" means any natural person.
"Program" refers to the lead poisoning prevention program in the Department.
"Satisfactory specimen" means a specimen collected using an appropriate procedure which is suitable in both blood quantity and quality to perform screening for Blood Lead measurement. Federal CLIA '88 regulations require that the laboratory requisitions contain sufficient patient data that must include patient's name, date of birth, date of collection, test(s) to be performed, and name and address of person requesting the test.
"Submitter" any health care provider (primary and non-primary), hospital, physician, laboratory, or other facility that submits blood specimens for blood lead measurements.
"Target population" refers to any infant or child, 6 months to 72 months of age.
"Unsatisfactory specimen" a blood specimen which is not suitable in quality or quantity to perform blood lead measurements.
[Source: Added at 12 Ok Reg 3055, eff 7-27-95]